RAVULIZUMAB vs REGORAFENIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RAVULIZUMAB vs REGORAFENIB: Safety Overview
| Metric | RAVULIZUMAB | REGORAFENIB |
|---|---|---|
| Total FAERS Reports | 118 | 9,441 |
| Deaths Reported | 11 | 1,869 |
| Death Rate | 9.3% | 19.8% |
| Hospitalizations | 89 | 3,363 |
| Average Patient Age | 48.4 yrs | 62.2 yrs |
| % Female Patients | 56.3% | 39.9% |
| FDA Approval Date | N/A | Jan 13, 2025 |
| Manufacturer | Alexion Pharmaceuticals Inc. | Bayer HealthCare Pharmaceuticals Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | N/A | Prescription |